-
Industries
-
Solutions
-
PeopleSearch By NameAdvanced Search
-
Insights & Experience
The Potential — and Pitfalls — of Biosimilars
Guidehouse on Healthcare Podcast
With a global forecast of $30 billion by 2020, biosimilars of market-leading therapeutics are a reality. Why, then, would lower-cost medications mean lower provider profits? Here, we discuss how reimbursement is an obstacle to broad adoption.
Back to top